Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

29 trials 23 recruiting Academic / non-commercial Merged from 2 name variants

Filter these 29 trials by condition, phase, country and more.

Open in Search →

29 Registered trials

23 Recruiting

2 Completed trials

2 Countries active

45 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 8 Phase II: 10 Phase I/II: 1 Phase III/IV: 1 Phase IV: 7 Phase I (FiH): 2

Oversight events:

1 unexpected event across 1 trial

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Antibiotic prophylaxis 1 Squamous cell carcinoma of the hypopharynx 1 Oropharyngeal squamous cell carcinoma 1 Laryngeal squamous cell carcinoma 1 Hepatic fibrosis 1 Squamous cell carcinoma of the oral cavity 1

Top IMPs

IZAFLORTAUCIPIR (18F) 3 BENDAMUSTINE HYDROCHLORIDE 2 CYCLOPHOSPHAMIDE MONOHYDRATE 2 FIBRIN MATRIX 2 FLUDARABINE PHOSPHATE 2 TOCILIZUMAB 2 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE 1 ACETYLSALICYLIC ACID 1 AFATINIB 1 AMIODARONE HYDROCHLORIDE 1 AMOXICILLIN, CLAVULANIC ACID 1 ATORVASTATIN 1

All trials — page 2

29 total

Multicenter, randomized, double-blind, parallel-group clinical trial to evaluate the efficacy and safety of Safinamide versus Rasagiline in … Recruiting

2023-503713-29-00 Phase IV 1 country
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo i… Recruiting

2024-510959-35-00 Phase II 1 country DONEPEZIL HYDROCHLORIDE
Impact of Exercise and Mediterranean diet vs Aspirin on live-birth rate and cardiovascular programming in In Vitro Fertilization (MEDITATE-I… Recruiting

2024-515590-10-00 Phase III 1 country ACETYLSALICYLIC ACID
HOPE study Ended

2024-516642-19-01 Phase IV 1 country LABETALOL HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE; URAPIDIL
Identification and clinical relevance of an oxytocin-deficient state: randomized, crossover, placebo-controlled pilot physiopathological stu… Ended

2024-515588-67-00 Phase I/II 1 country EXENATIDE

Showing 25–29 of 29 trials

← All sponsors A–Z